SCHEMBL23920139

SCHEMBL23920139

Clc1ccc2oc(I)cc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.55
KDM4E B2RXH2 5/20 0.47
GPR35 Q9HC97 2/20 0.47
CYP1A2 P05177 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP2C9 P11712 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
KMT2A Q03164 1/20 0.46
CA12 O43570 1/20 0.46
CA9 Q16790 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.41
HSD17B10 Q99714 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14231749 0.77 MAOB (0.59) MAOBKDM4EGPR35CYP1A2ALDH1A1
SCHEMBL1618338 0.76 MAOB (0.68) MAOBKDM4EGPR35CYP1A2ALDH1A1
SCHEMBL15031527 0.74 MAOB (0.55) MAOBKDM4EGPR35CYP1A2ALDH1A1
SCHEMBL2090135 0.74 MAOB (0.55) MAOBKDM4EGPR35CYP1A2ALDH1A1
SCHEMBL434464 0.74 MAOB (0.55) MAOBKDM4EGPR35CYP1A2ALDH1A1
SCHEMBL15031529 0.74 MAOB (0.55) MAOBKDM4EGPR35CYP1A2ALDH1A1
SCHEMBL25824461 0.74 MAOB (0.55) MAOBKDM4EGPR35CYP1A2ALDH1A1
SCHEMBL28117929 0.74 MAOB (0.55) MAOBKDM4EGPR35CYP1A2ALDH1A1
SCHEMBL12778679 0.74 FLT3 (0.55) MAOBKDM4EALDH1A1CA2KMT2A
SCHEMBL18003606 0.74 CA12 (0.46) CYP1A2CA1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230047589-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ALTOS LABS, INC. 2023-02-16 US disclosed
US-11230542-B2 Inhibitors of integrated stress response pathway Praxis Biotech LLC (US) 2022-01-25 US disclosed
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ALTOS LABS, INC. 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, DDIT3, ATF1 MAOB 2567/4885KDM4E 4626/4885GPR35 4131/4885
US-11230542-B2 Inhibitors of integrated stress response pathway ATF4, DDIT3, ATF1 MAOB 2567/4885KDM4E 4626/4885GPR35 4131/4885
US-20230047589-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, DDIT3, ATF1 MAOB 2567/4885KDM4E 4626/4885GPR35 4131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.